company-logo

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.

Ocean Biomedical Dividend Announcement

Ocean Biomedical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Ocean Biomedical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Ocean Biomedical Dividend History

Ocean Biomedical Dividend Yield

Ocean Biomedical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Ocean Biomedical stock? Use our calculator to estimate your expected dividend yield:

Ocean Biomedical Financial Ratios

P/E ratio-0.42
PEG ratio0.00
P/B ratio-0.20
ROE75.64%
Payout ratio0.00%
Current ratio0.07
Quick ratio0.07
Cash Ratio0.00

Ocean Biomedical Dividend FAQ

Does Ocean Biomedical stock pay dividends?
Ocean Biomedical does not currently pay dividends to its shareholders.
Has Ocean Biomedical ever paid a dividend?
No, Ocean Biomedical has no a history of paying dividends to its shareholders. Ocean Biomedical is not known for its dividend payments.
Why doesn't Ocean Biomedical pay dividends?
There are several potential reasons why Ocean Biomedical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Ocean Biomedical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Ocean Biomedical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Ocean Biomedical a dividend aristocrat?
Ocean Biomedical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Ocean Biomedical a dividend king?
Ocean Biomedical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Ocean Biomedical a dividend stock?
No, Ocean Biomedical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Ocean Biomedical stocks?
To buy Ocean Biomedical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Ocean Biomedical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.